Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Martin Zamora

Concepts (273)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Transplantation
31
2023
246
6.220
Why?
Cytomegalovirus Infections
7
2012
182
1.800
Why?
Antiviral Agents
12
2023
651
1.560
Why?
Respiratory Syncytial Virus Infections
4
2023
97
1.400
Why?
Lung Diseases
7
2017
710
1.180
Why?
Postoperative Complications
9
2015
2161
0.850
Why?
Bronchiolitis Obliterans
7
2015
66
0.830
Why?
Ganciclovir
5
2012
49
0.820
Why?
Respiratory Syncytial Virus, Human
1
2023
60
0.810
Why?
alpha 1-Antitrypsin Deficiency
2
2018
78
0.610
Why?
Graft Rejection
9
2018
533
0.600
Why?
Pneumonia, Viral
1
2023
344
0.600
Why?
Heart Transplantation
6
2016
671
0.580
Why?
Lung
11
2017
3672
0.550
Why?
Pulmonary Medicine
1
2017
88
0.550
Why?
Regeneration
1
2017
162
0.530
Why?
Sirolimus
3
2018
192
0.520
Why?
Diltiazem
1
2014
23
0.470
Why?
Bronchial Arteries
2
2010
11
0.450
Why?
RNA, Small Interfering
2
2015
544
0.420
Why?
Organ Transplantation
3
2018
161
0.420
Why?
Transplant Recipients
1
2014
143
0.420
Why?
Graft Survival
5
2018
480
0.410
Why?
Pulmonary Circulation
2
2010
407
0.390
Why?
Patient Selection
6
2015
654
0.370
Why?
Polymorphism, Genetic
1
2014
621
0.370
Why?
Epstein-Barr Virus Infections
1
2011
71
0.360
Why?
Histocompatibility Antigens Class I
1
2012
174
0.360
Why?
Transplantation, Homologous
10
2018
397
0.360
Why?
Histocompatibility Antigens Class II
1
2012
353
0.350
Why?
Herpesviridae Infections
1
2011
138
0.350
Why?
RNA Interference
2
2013
438
0.340
Why?
Virus Diseases
1
2011
200
0.330
Why?
Treatment Outcome
10
2023
9159
0.330
Why?
Societies, Medical
4
2018
684
0.330
Why?
Pulmonary Emphysema
4
2015
316
0.320
Why?
Respiratory Tract Infections
1
2011
323
0.290
Why?
Cytomegalovirus
2
2004
146
0.280
Why?
Humans
41
2023
115587
0.280
Why?
Gene Expression Regulation
3
2014
2353
0.270
Why?
Capillaries
1
2005
92
0.250
Why?
Autoantibodies
2
2013
1360
0.250
Why?
Vasculitis
1
2005
71
0.250
Why?
Immunosuppressive Agents
4
2014
666
0.240
Why?
Drug Resistance, Viral
3
2011
99
0.240
Why?
Pulmonary Disease, Chronic Obstructive
5
2015
1098
0.240
Why?
Waiting Lists
3
2015
223
0.230
Why?
Immunoglobulins, Intravenous
1
2004
123
0.220
Why?
Reperfusion Injury
3
2017
254
0.220
Why?
Lymphocyte Function-Associated Antigen-1
2
2018
34
0.220
Why?
Risk Factors
7
2013
8697
0.220
Why?
Heart-Lung Transplantation
2
2014
10
0.220
Why?
Pneumonectomy
2
2018
126
0.210
Why?
Consensus
2
2016
532
0.210
Why?
Evidence-Based Medicine
1
2005
684
0.190
Why?
Middle Aged
14
2015
26999
0.170
Why?
Transplantation Tolerance
1
2018
31
0.160
Why?
Endothelial Cells
2
2013
695
0.150
Why?
Primary Graft Dysfunction
2
2017
32
0.150
Why?
Bronchoalveolar Lavage Fluid
4
2020
608
0.140
Why?
Adult
9
2023
30718
0.140
Why?
Transplantation, Heterotopic
2
2014
16
0.140
Why?
Male
18
2015
55949
0.140
Why?
CD4-Positive T-Lymphocytes
2
2014
965
0.140
Why?
Respiratory Function Tests
2
2010
535
0.140
Why?
Immune Tolerance
1
2018
332
0.140
Why?
Frailty
1
2018
116
0.130
Why?
DNA, Mitochondrial
1
2017
185
0.130
Why?
Syndrome
3
2015
339
0.130
Why?
Congresses as Topic
1
2017
204
0.130
Why?
Tissue Donors
2
2016
331
0.130
Why?
Female
17
2018
59913
0.130
Why?
International Cooperation
1
2016
174
0.130
Why?
Follow-Up Studies
3
2014
4440
0.120
Why?
Interleukin-18
2
2013
222
0.120
Why?
Fas Ligand Protein
1
2014
59
0.120
Why?
Asphyxia
1
2014
21
0.120
Why?
Cytochrome P-450 CYP2C8
1
2014
15
0.120
Why?
Tissue and Organ Procurement
2
2015
243
0.120
Why?
Extracorporeal Membrane Oxygenation
2
2015
243
0.120
Why?
Aryl Hydrocarbon Hydroxylases
1
2014
41
0.120
Why?
Everolimus
1
2014
63
0.120
Why?
Receptors, Steroid
1
2014
52
0.110
Why?
Anastomosis, Surgical
2
2013
140
0.110
Why?
Perfusion
1
2014
150
0.110
Why?
Cytochrome P-450 CYP3A
1
2014
62
0.110
Why?
Tobacco Smoke Pollution
2
2013
221
0.110
Why?
Health Resources
1
2015
122
0.110
Why?
Ventilator-Induced Lung Injury
1
2014
49
0.110
Why?
CD146 Antigen
1
2013
38
0.110
Why?
Tissue Distribution
1
2014
324
0.110
Why?
CD8-Positive T-Lymphocytes
1
2018
693
0.110
Why?
Demography
1
2014
261
0.110
Why?
Practice Guidelines as Topic
2
2018
1405
0.100
Why?
Predictive Value of Tests
3
2013
1805
0.100
Why?
Animals
12
2018
32102
0.100
Why?
Immunocompromised Host
2
2011
197
0.100
Why?
Vasodilator Agents
1
2014
308
0.100
Why?
Metabolic Clearance Rate
1
2012
108
0.100
Why?
Injections, Intravenous
1
2012
204
0.100
Why?
Seroepidemiologic Studies
1
2012
140
0.100
Why?
Liver Transplantation
1
2018
830
0.090
Why?
Cytokines
2
2010
1853
0.090
Why?
Double-Blind Method
2
2015
1660
0.090
Why?
Viral Vaccines
1
2011
90
0.090
Why?
Length of Stay
1
2015
958
0.090
Why?
Respiration, Artificial
1
2014
526
0.090
Why?
Airway Remodeling
1
2010
60
0.090
Why?
Cell Communication
1
2012
282
0.090
Why?
Cross-Over Studies
1
2012
434
0.090
Why?
Neprilysin
1
2010
47
0.090
Why?
Preoperative Care
1
2012
318
0.080
Why?
CD4 Antigens
1
2010
124
0.080
Why?
Gene Expression
1
2014
1435
0.080
Why?
Referral and Consultation
1
2014
646
0.080
Why?
Cost of Illness
1
2011
257
0.080
Why?
Adoptive Transfer
1
2010
199
0.080
Why?
T-Lymphocytes, Cytotoxic
1
2010
156
0.080
Why?
Biomarkers
3
2014
3466
0.080
Why?
Pulmonary Fibrosis
2
2013
330
0.080
Why?
Pulmonary Artery
2
2012
1031
0.080
Why?
Genotype
1
2014
1786
0.080
Why?
Blood Specimen Collection
1
2008
32
0.080
Why?
Regional Blood Flow
1
2010
414
0.080
Why?
Administration, Inhalation
1
2010
644
0.080
Why?
Macrophages
2
2013
1284
0.080
Why?
Bacteriological Techniques
1
2008
65
0.080
Why?
C-Reactive Protein
1
2010
364
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
930
0.080
Why?
Recurrence
1
2011
952
0.080
Why?
Macrophages, Alveolar
2
2013
357
0.080
Why?
Body Temperature
1
2008
211
0.080
Why?
Dose-Response Relationship, Drug
1
2012
1870
0.070
Why?
Fever
1
2008
280
0.070
Why?
Nurse Practitioners
1
2008
105
0.070
Why?
Time Factors
5
2015
6165
0.070
Why?
Trachea
2
2007
233
0.070
Why?
Bacteremia
1
2008
159
0.070
Why?
Terminology as Topic
1
2007
186
0.070
Why?
Prognosis
1
2014
3339
0.070
Why?
Mice, Inbred BALB C
3
2018
1168
0.070
Why?
Aged
7
2014
19251
0.060
Why?
Practice Patterns, Physicians'
1
2014
1180
0.060
Why?
Antibodies, Monoclonal
2
2018
1265
0.060
Why?
Cryptogenic Organizing Pneumonia
1
2005
17
0.060
Why?
Tissue Transplantation
1
2005
11
0.060
Why?
Mice
8
2014
15052
0.060
Why?
Calcineurin Inhibitors
1
2005
59
0.060
Why?
CD40 Ligand
1
2005
42
0.060
Why?
Survival
1
2004
37
0.060
Why?
Rats
4
2013
5034
0.060
Why?
Mice, Inbred C3H
2
2018
244
0.060
Why?
T-Lymphocytes
1
2012
1756
0.060
Why?
Registries
1
2012
1770
0.060
Why?
Immunoglobulins
1
2004
147
0.060
Why?
Hypoxia
1
2010
937
0.060
Why?
Drug Resistance
1
2004
162
0.060
Why?
Cross-Sectional Studies
1
2014
4435
0.060
Why?
Rats, Sprague-Dawley
3
2013
2262
0.060
Why?
Drug Administration Schedule
1
2005
724
0.050
Why?
Torsion Abnormality
1
2003
17
0.050
Why?
Quality Assurance, Health Care
1
2005
315
0.050
Why?
Capillary Permeability
2
2013
138
0.050
Why?
Respiratory Mucosa
1
2005
258
0.050
Why?
Fibrosis
1
2005
457
0.050
Why?
Prevalence
1
2009
2264
0.050
Why?
Incidence
1
2009
2335
0.050
Why?
Young Adult
3
2014
10470
0.050
Why?
Genomics
1
2006
645
0.050
Why?
Mice, Inbred C57BL
3
2018
4773
0.050
Why?
Mice, Transgenic
2
2018
1970
0.050
Why?
Polymerase Chain Reaction
1
2004
1000
0.050
Why?
Endothelium, Vascular
1
2007
845
0.050
Why?
Neutrophils
1
2006
1172
0.050
Why?
Polyphosphates
1
2020
33
0.050
Why?
Mice, Knockout
3
2013
2604
0.050
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2013
88
0.050
Why?
Transplantation Immunology
2
2013
31
0.050
Why?
Prospective Studies
1
2012
6264
0.050
Why?
Adolescent
4
2014
17889
0.040
Why?
Case-Control Studies
3
2013
3022
0.040
Why?
Early Diagnosis
2
2013
220
0.040
Why?
Ribavirin
1
2020
89
0.040
Why?
Mice, Inbred Strains
2
2013
399
0.040
Why?
Health Care Rationing
1
2018
47
0.040
Why?
Retrospective Studies
3
2015
12608
0.040
Why?
CD28 Antigens
1
2018
47
0.040
Why?
Immunohistochemistry
2
2013
1642
0.040
Why?
Cyclosporine
1
2018
169
0.040
Why?
Gene Expression Profiling
1
2004
1536
0.040
Why?
Cell Line
2
2013
2651
0.040
Why?
DNA Repair
1
2017
190
0.030
Why?
Acute Disease
2
2010
914
0.030
Why?
Isoantibodies
1
2016
52
0.030
Why?
Cell Movement
2
2012
867
0.030
Why?
DNA Damage
1
2017
357
0.030
Why?
Genes, RAG-1
1
2014
11
0.030
Why?
Reactive Oxygen Species
1
2017
549
0.030
Why?
Lymphocyte Activation
1
2018
1057
0.030
Why?
Tidal Volume
1
2014
74
0.030
Why?
Positive-Pressure Respiration
1
2014
68
0.030
Why?
Sensitivity and Specificity
2
2008
1718
0.030
Why?
Chemokine CCL5
1
2013
46
0.030
Why?
Patient Admission
1
2015
175
0.030
Why?
Gene Deletion
1
2014
355
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2013
68
0.030
Why?
Aorta, Abdominal
1
2013
38
0.030
Why?
Pulmonary Edema
1
2013
116
0.030
Why?
Immunity, Innate
1
2018
731
0.030
Why?
Neck
1
2013
84
0.030
Why?
Abdomen
1
2013
104
0.030
Why?
Inhalation Exposure
1
2013
102
0.030
Why?
Child
1
2011
18488
0.030
Why?
History, 21st Century
1
2013
162
0.030
Why?
Rats, Nude
1
2012
27
0.030
Why?
Cardiomegaly
1
2013
161
0.030
Why?
Fluoresceins
1
2012
46
0.030
Why?
Tobacco Products
1
2013
99
0.030
Why?
History, 20th Century
1
2013
273
0.020
Why?
Cell Death
1
2013
326
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2013
350
0.020
Why?
Familial Primary Pulmonary Hypertension
1
2012
191
0.020
Why?
Survival Rate
1
2015
1650
0.020
Why?
Transfection
1
2013
866
0.020
Why?
United States
2
2018
12295
0.020
Why?
Aorta, Thoracic
1
2013
246
0.020
Why?
Myocytes, Cardiac
1
2014
457
0.020
Why?
Vascular Endothelial Growth Factor A
1
2013
503
0.020
Why?
Fluorescent Dyes
1
2012
304
0.020
Why?
H-2 Antigens
1
2010
111
0.020
Why?
Oximetry
1
2010
80
0.020
Why?
Myocardium
1
2014
926
0.020
Why?
Patient Discharge
1
2015
770
0.020
Why?
Weight Loss
1
2013
633
0.020
Why?
False Positive Reactions
1
2008
109
0.020
Why?
Suicide
1
2014
501
0.020
Why?
Bronchoscopy
1
2010
245
0.020
Why?
Systemic Inflammatory Response Syndrome
1
2008
71
0.020
Why?
International Agencies
1
2007
29
0.020
Why?
Receptors, Interleukin-8B
1
2007
23
0.020
Why?
Blotting, Western
1
2010
1153
0.020
Why?
Pulmonary Alveoli
1
2010
376
0.020
Why?
Decompression, Surgical
1
2008
93
0.020
Why?
Microcirculation
1
2007
138
0.020
Why?
Evidence-Based Practice
1
2008
191
0.020
Why?
Biopsy, Needle
1
2007
183
0.020
Why?
Cell Survival
1
2010
1024
0.020
Why?
Chemotaxis, Leukocyte
1
2006
130
0.020
Why?
Reoperation
1
2008
525
0.020
Why?
Cells, Cultured
1
2013
3914
0.020
Why?
Oxygen
1
2010
837
0.020
Why?
Transplantation Chimera
1
2005
51
0.020
Why?
Eosinophilia
1
2007
186
0.020
Why?
Inpatients
1
2008
380
0.020
Why?
Cell Proliferation
1
2012
2194
0.020
Why?
Models, Biological
1
2012
1646
0.020
Why?
Ischemia
1
2007
363
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2006
746
0.010
Why?
Biopsy
1
2007
1056
0.010
Why?
Respiratory System
1
2005
141
0.010
Why?
Disease Models, Animal
1
2013
3580
0.010
Why?
Diagnosis, Differential
1
2007
1357
0.010
Why?
Kinetics
1
2006
1569
0.010
Why?
Surveys and Questionnaires
1
2014
4665
0.010
Why?
Pneumonia
1
2007
576
0.010
Why?
Reproducibility of Results
1
2008
2800
0.010
Why?
Chronic Disease
1
2007
1598
0.010
Why?
Immunotherapy
1
2005
479
0.010
Why?
Hypertension, Pulmonary
1
2012
1749
0.010
Why?
Tomography, X-Ray Computed
1
2010
2392
0.010
Why?
Transcription, Genetic
1
2004
1310
0.010
Why?
RNA, Messenger
1
2004
2574
0.010
Why?
Inflammation
1
2005
2499
0.010
Why?
Zamora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)